title: Bladder management in multiple sclerosis.
abstract: This article reviews the basic principles and therapeutic options in the management of the neurogenic bladder due to multiple sclerosis (MS), written primarily for the non-urology provider. An algorithm for the initial management of the MS patient with lower urinary tract symptoms is provided.
authors: Department of Urology, University of Washington, Box 356510, Seattle, WA 98195-6510, USA. Electronic address: cyang@u.washington.edu.
authors: Claire C
authors: CC
authors: Yang
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001521:Behavior Therapy; D001905:Botulinum Toxins / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004599:Electric Stimulation Therapy; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D001750:Urinary Bladder, Neurogenic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D014546:Urinary Catheterization; D014547:Urinary Diversion; D014551:Urinary Tract / Q000033:anatomy & histology; D014553:Urinary Tract Physiological Phenomena
chemical_list: D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D001905:Botulinum Toxins
keywords: Bladder; Neurogenic bladder; Treatment; Urinary tract